At the beginning of the current pandemic, we offered the use of our PrecisionLife® platform to the global research community to analyze large scale, multi-omic, clinical and epidemiological data for COVID-19 datasets.
Since then we have worked with several international groups around our analysis results. We have generated multiple insights into the genetics, clinical presentation, pathology and treatment of COVID-19 patients that would not have been possible with existing analysis tools.
We continue to run new studies and to post new pre-prints and manuscripts. We have placed all of our COVID-19 results into the public domain. This has led us to working closely with scientists and clinicians battling the COVID-19 pandemic across the US, Denmark, Germany, Taiwan, and the UK.
If you’re interested in collaborating with us, have a COVID-19 dataset or would like more information on previous studies, please contact us at covid-19@precisionlife.com.
